Oral Contraception Inducing Bullous Pemphigoid in an Adolescent

Main Article Content

Margaret C Wheless
Blake Reid Zelickson
Tejesh S Patel
Allison V Jones


bullous pemphigoid, drug reactions, vesiculobullous dermatoses


Abstract not available.


1. Amber, K., Murrell, D., Schmidt, E., Joly, P. and Borradori, L. (2017). Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management. Clinical Reviews in Allergy & Immunology, 54(1), pp.26-51.

2. Honeyman, J., Eguiguren, G., Pinto, A., Honeyman, A., de la Parra, M. and Navarrete, W. (1981). Bullous dermatoses of pregnancy. Archives of Dermatology, 117(5), pp.264-267.

3. Patsatsi, A., Kyriakou, A. and Werth, V. (2019). Bullous pemphigoid in adolescence. Pediatric Dermatology, 36(2), pp.184-188.

4. Polansky, M., Eisenstadt, R., DeGrazia, T., Zhao, X., Liu, Y. and Feldman, R. (2019). Rituximab Therapy in Patients with Bullous Pemphigoid: A Retrospective Study of 20 Patients. Journal of the American Academy of Dermatology.

5. Stavropoulos, P., Soura, E. and Antoniou, C. (2014). Drug-induced pemphigoid: a review of the literature. Journal of the European Academy of Dermatology and Venereology, 28(9), pp.1133-1140.

6. Tandon, V., Mahajan, A. and Sharma, S. (2008). Tibolone induced Bullous pemphigoid. JK Science Journal, 10(1), pp.26-27.